All SEC Filings :: Avalo Therapeutics, Inc. (AVTX)

Filing Type:

Year:

Date	Form	Description	Pages
12/05/24	8-K	Current report filing Documents EX-99.1	28
11/14/24	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	5
11/14/24	4	Statement of changes in beneficial ownership of securities	1
11/14/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	10
11/12/24	8-K	Current report filing Documents EX-99.1 EX-99.2	33
11/07/24	SC 13G/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	3
11/07/24	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-FILING FEES EX-5.1 EX-23.1	9
11/07/24	S-8	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Documents EX-FILING FEES EX-5.1 EX-23.1	9
11/07/24	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.4 EX-31.1 EX-31.2 EX-32.1	54
11/07/24	8-K	Current report filing Documents EX-99.1	9